Publication

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial

Eppinga, R. N., Hartman, M. H. T., van Veldhuisen, D. J., Lexis, C. P. H., Connelly, M. A., Lipsic, E., van der Horst, I. C. C., van der Harst, P. & Dullaart, R. P. F., 25-Jan-2016, In : PLoS ONE. 11, 1, 15 p., e0145719.

Research output: Contribution to journalArticleAcademicpeer-review

Objective

Metformin affects low density lipoprotein (LDL) and high density (HDL) subfractions in the context of impaired glucose tolerance, but its effects in the setting of acute myocardial infarction (MI) are unknown. We determined whether metformin administration affects lipoprotein subfractions 4 months after ST-segment elevation MI (STEMI). Second, we assessed associations of lipoprotein subfractions with left ventricular ejection fraction (LVEF) and infarct size 4 months after STEMI.

Methods

371 participants without known diabetes participating in the GIPS-III trial, a placebo controlled, double-blind randomized trial studying the effect of metformin (500 mg bid) during 4 months after primary percutaneous coronary intervention for STEMI were included of whom 317 completed follow-up (clinicaltrial.gov Identifier: NCT01217307). Lipoprotein subfractions were measured using nuclear magnetic resonance spectroscopy at presentation, 24 hours and 4 months after STEMI. (Apo)lipoprotein measures were obtained during acute STEMI and 4 months post-STEMI. LVEF and infarct size were measured by cardiac magnetic resonance imaging.

Results

Metformin treatment slightly decreased LDL cholesterol levels (adjusted P = 0.01), whereas apoB remained unchanged. Large LDL particles and LDL size were also decreased after metformin treatment (adjusted P <0.001). After adjustment for covariates, increased small HDL particles at 24 hours after STEMI predicted higher LVEF (P = 0.005). In addition, increased medium-sized VLDL particles at the same time point predicted a smaller infarct size (P <0.001).

Conclusion

LDL cholesterol and large LDL particles were decreased during 4 months treatment with metformin started early after MI. Higher small HDL and medium VLDL particle concentrations are associated with favorable LVEF and infarct size.

Original languageEnglish
Article numbere0145719
Number of pages15
JournalPLoS ONE
Volume11
Issue number1
Publication statusPublished - 25-Jan-2016

    Keywords

  • HIGH-DENSITY-LIPOPROTEIN, MAGNETIC-RESONANCE-SPECTROSCOPY, LEFT-VENTRICULAR FUNCTION, ARTERY-DISEASE, INSULIN-RESISTANCE, CAROTID ATHEROSCLEROSIS, PARTICLE NUMBER, HEART-DISEASE, CHOLESTEROL, RISK
Related Datasets
  1. GIPS-III

    Harst, van der, P. (Creator), University of Groningen, 2017

    Dataset

View all (1) »

Download statistics

No data available

ID: 40980962